Cambridge Heart launches enhanced website
Cambridge Heart (Tewksbury, Massachusetts), a maker of non-invasive diagnostic tests for cardiac disease, has launched an updated, feature-rich website at www.cambridgeheart.com.
The new site features updated content in a variety of multimedia formats and addresses the company's key audiences including clinicians, patients and investors. New graphics, increased functionality and improved navigation to allow users to easily access important information about sudden cardiac arrest and to learn about Cambridge Heart's Microvolt T-Wave Alternans (MTWA) diagnostic test.
Patients can now use the website to locate testing facilities in their area that offer the MTWA test.
“As the MTWA test continues to be embraced by the medical community through our partnership with Cardiac Science, it is important that we provide a resource for clinicians and patients who are interested in learning more about how MTWA testing can help identifying and managing patients at risk for sudden cardiac arrest,“ said Ali Haghighi-Mood, CEO, Cambridge Heart.
Promega building new facility
Promega (Madison, Wisconsin) has broken ground for a “Current Good Manufacturing Practice“ (cGMP) facility dedicated to accommodate business growth and its customers who need FDA-regulated molecular biology products. These include components such as sample preparation systems and reagents which are part of diagnostic and medical tests sold by human diagnostic test providers.
The 260,000 square foot facility will employ an additional 100 people in the next five years. Most of the building will be dedicated to manufacturing with both committed (fixed) production lines and flexible manufacturing areas. The building will also have a customer experience center for employees and guests that will include spaces for training, laboratory demonstrations, conferences, an exercise and fitness center, and dining.
“Molecular biology opens doors not only to new understanding of life, but to practical applications that enhance the health of our citizens,“ said CEO Bill Linton. “We have a tremendous team at Promega who continue to diversify our capabilities to support the needs of our customers. This building is our next step in expanding our product supply capabilities worldwide.“
Promega provides innovative solutions and technical support to the life sciences industry.